Cargando…

Natamycin versus natamycin combined with voriconazole in the treatment of fungal keratitis

OBJECTIVE: To observe the therapeutic effect of natamycin combined with voriconazole in the treatment of fungal keratitis (FK). METHODS: This is a retrospective study. The subjects of this study were 64 patients with FK who were admitted to Baoding No.1 Central Hospital from February 2019 to July 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Jingjing, Yang, Chengwen, Wei, Qiuhong, Lian, Huifang, An, Lin, Zhang, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214786/
https://www.ncbi.nlm.nih.gov/pubmed/37250561
http://dx.doi.org/10.12669/pjms.39.3.6908
_version_ 1785047910724927488
author Cai, Jingjing
Yang, Chengwen
Wei, Qiuhong
Lian, Huifang
An, Lin
Zhang, Rong
author_facet Cai, Jingjing
Yang, Chengwen
Wei, Qiuhong
Lian, Huifang
An, Lin
Zhang, Rong
author_sort Cai, Jingjing
collection PubMed
description OBJECTIVE: To observe the therapeutic effect of natamycin combined with voriconazole in the treatment of fungal keratitis (FK). METHODS: This is a retrospective study. The subjects of this study were 64 patients with FK who were admitted to Baoding No.1 Central Hospital from February 2019 to July 2022. The enrolled patients were divided into control group (n= 32) and study group (n= 32) by the random number table method. The control group was treated with natamycin alone, and the study group was treated with natamycin combined with voriconazole. The total efficacy, time of disappearance of ocular symptoms, visual acuity level, keratitis severity score, corneal ulcer area, tear fungus index and incidence of adverse reactions were compared between the two groups. RESULTS: The total efficacy,of the study group was significantly higher than that of the control group. The disappearance time of corneal ulcer, photophobia, foreign body sensation and hypopyon in the study group was shorter than those in the control group. Keratitis severity score and (1,3)-β-D-glucan level in the study group were lower than those in the control group. The corneal ulcer area was narrowed in the study group than that of the control group, and the visual acuity level in the former group was higher than that of the latter group. Besides, there was no significant difference in the frequency of adverse reactions between the two groups. CONCLUSION: Natamycin combined with voriconazole is safe and effective in the treatment of FK.
format Online
Article
Text
id pubmed-10214786
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Professional Medical Publications
record_format MEDLINE/PubMed
spelling pubmed-102147862023-05-27 Natamycin versus natamycin combined with voriconazole in the treatment of fungal keratitis Cai, Jingjing Yang, Chengwen Wei, Qiuhong Lian, Huifang An, Lin Zhang, Rong Pak J Med Sci Original Article OBJECTIVE: To observe the therapeutic effect of natamycin combined with voriconazole in the treatment of fungal keratitis (FK). METHODS: This is a retrospective study. The subjects of this study were 64 patients with FK who were admitted to Baoding No.1 Central Hospital from February 2019 to July 2022. The enrolled patients were divided into control group (n= 32) and study group (n= 32) by the random number table method. The control group was treated with natamycin alone, and the study group was treated with natamycin combined with voriconazole. The total efficacy, time of disappearance of ocular symptoms, visual acuity level, keratitis severity score, corneal ulcer area, tear fungus index and incidence of adverse reactions were compared between the two groups. RESULTS: The total efficacy,of the study group was significantly higher than that of the control group. The disappearance time of corneal ulcer, photophobia, foreign body sensation and hypopyon in the study group was shorter than those in the control group. Keratitis severity score and (1,3)-β-D-glucan level in the study group were lower than those in the control group. The corneal ulcer area was narrowed in the study group than that of the control group, and the visual acuity level in the former group was higher than that of the latter group. Besides, there was no significant difference in the frequency of adverse reactions between the two groups. CONCLUSION: Natamycin combined with voriconazole is safe and effective in the treatment of FK. Professional Medical Publications 2023 /pmc/articles/PMC10214786/ /pubmed/37250561 http://dx.doi.org/10.12669/pjms.39.3.6908 Text en Copyright: © Pakistan Journal of Medical Sciences https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0 (https://creativecommons.org/licenses/by/3.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Cai, Jingjing
Yang, Chengwen
Wei, Qiuhong
Lian, Huifang
An, Lin
Zhang, Rong
Natamycin versus natamycin combined with voriconazole in the treatment of fungal keratitis
title Natamycin versus natamycin combined with voriconazole in the treatment of fungal keratitis
title_full Natamycin versus natamycin combined with voriconazole in the treatment of fungal keratitis
title_fullStr Natamycin versus natamycin combined with voriconazole in the treatment of fungal keratitis
title_full_unstemmed Natamycin versus natamycin combined with voriconazole in the treatment of fungal keratitis
title_short Natamycin versus natamycin combined with voriconazole in the treatment of fungal keratitis
title_sort natamycin versus natamycin combined with voriconazole in the treatment of fungal keratitis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214786/
https://www.ncbi.nlm.nih.gov/pubmed/37250561
http://dx.doi.org/10.12669/pjms.39.3.6908
work_keys_str_mv AT caijingjing natamycinversusnatamycincombinedwithvoriconazoleinthetreatmentoffungalkeratitis
AT yangchengwen natamycinversusnatamycincombinedwithvoriconazoleinthetreatmentoffungalkeratitis
AT weiqiuhong natamycinversusnatamycincombinedwithvoriconazoleinthetreatmentoffungalkeratitis
AT lianhuifang natamycinversusnatamycincombinedwithvoriconazoleinthetreatmentoffungalkeratitis
AT anlin natamycinversusnatamycincombinedwithvoriconazoleinthetreatmentoffungalkeratitis
AT zhangrong natamycinversusnatamycincombinedwithvoriconazoleinthetreatmentoffungalkeratitis